Image 01 Image 03

Medicine Tag

Novavax might give America its fourth COVID-19 vaccine after a trial showed it is 90.4% overall efficient. The vaccine also protects people from moderate and severe COVID-19 in the PREVENT-19 Phase 3 trial.